The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Therapeutic strategies for Parkinson’s disease: the ancient meets the future–traditional Chinese herbal medicine, electroacupuncture, gene therapy and stem cells
Abstract
In China, it has been estimated that there are more than 2.0 million people suffering from Parkinson's disease, which is currently becoming one of the most common chronic neurodegenerative disorders during recent years. For many years, scientists have struggled to find new therapeutic approaches for this disease. Since 1994, our research group led by Drs. Ji-Sheng Han and Xiao-Min Wang of Neuroscience Research Institute, Peking University has developed several prospective treatment strategies for the disease. These studies cover the traditional Chinese medicine-herbal formula or acupuncture, and modern technologies such as gene therapy or stem cell replacement therapy, and have achieved some original results. It hopes that these data may be beneficial for the research development and for the future clinical utility for treatment of Parkinson's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Reynolds, B. A., & Weiss, S. (1992) · Science · doi:10.1126/science.1553558 · Cited by 4,482 · cited 1×
“Meanwhile, more and more researches have focused on the embryonic stem (ES) cell transplantation therapy for PD in recent years, especially after 1998, the human ES cells were cultured successfully in vitro [50, 51].”
BackgroundTransplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. Q., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441002 · Cited by 2,366
Wiklund, R. A., & Rosenbaum, S. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371606 · Cited by 2,149
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
Direct isolation of human central nervous system stem cells
Uchida, N., Buck, D. W., He, D., Reitsma, M. J., Masek, M., Phan, T. V., Tsukamoto, A. S., Gage, F. H., & Weissman, I. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14720 · Cited by 1,849 · cited 1×
“Since 1997, neural stem cells (NSCs) isolated from fetal brains have been cultivated in vitro and transplanted into animal models of PD to test their therapeutic efficacy [47–49].”
MethodInduction of Midbrain Dopaminergic Neurons from ES Cells by Stromal Cell–Derived Inducing Activity
Kawasaki, H., Mizuseki, K., Nishikawa, S., Kaneko, S., Kuwana, Y., Nakanishi, S., Nishikawa, S.-I., & Sasai, Y. (2000) · Neuron · doi:10.1016/s0896-6273(00)00083-0 · Cited by 1,277
Grafts of Fetal Dopamine Neurons Survive and Improve Motor Function in Parkinson's Disease
Lindvall, O., Brundin, P., Widner, H., Rehncrona, S., Gustavii, B., Frackowiak, R., Leenders, K. L., Sawle, G., Rothwell, J. C., Marsden, C. D., et al. (1990) · Science · doi:10.1126/science.2105529 · Cited by 1,207
TRANSPLANTATION OF EMBRYONIC DOPAMINE NEURONS FOR SEVERE PARKINSON'S DISEASE
Reed, R., Reene, P. A. E. G., Reeze, R. O. E. B., Ei, W., Ouchel, W. I. D. U. M., Ao, R. I. K., Infield, W., Ulver, S. H. C., Rojanowski, J. O. Q. T., Idelberg, D. A. E., et al. (2001) · Cited by 1,001
Brain Grafts Reduce Motor Abnormalities Produced by Destruction of Nigrostriatal Dopamine System
Perlow, M. J., Freed, W. J., Hoffer, B. J., Seiger, A., Olson, L., & Wyatt, R. J. (1979) · Science · doi:10.1126/science.571147 · Cited by 966 · cited 1×
“transplanted human fetal mesencephalic tissue derived from naturally aborted fetuses, rich in primary DAergic neurons, into the brain of PD rat models, and found that the defect in behavior was significantly improved [42].”
BackgroundSite-specific integration by adeno-associated virus.
Kotin, R. M., Siniscalco, M., Samulski, R. J., Zhu, X. D., Hunter, L., Laughlin, C. A., McLaughlin, S., Muzyczka, N., Rocchi, M., & Berns, K. I. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2211 · Cited by 868 · cited 1×
“All the characteristics above determined that AAV vector was promising in PD gene therapy [28, 29].”
Background
Research works printed but not linked: 3
- Gu M, Zhou HF, Xue B, Niu DB, Wang XM (2004) The effect of Chinese Herb Tripterygium Wilfordii Hook F. Monomer T10 on in vitro model of Alzheimer’s disease. Acta Physiol Sin 56:73–78
- Qian ZN, Gu ZL, Pan JX (1985) The effect of acupuncture analgesia on the monamine transmitters in the rat striatum and spinal cord. Zhen Ci Yan Jiu 13:199–121
- Xu GH, Ling Y, Wan Y, Wang XM, Han JS (1998) Construction of recombinant adenovirus expressing human tyrosine hydroxylase gene and study of its activityes in vitro. Chinese J Neuroanatomy 14:313–317
Cited by
Anti-Parkinsonian drug discovery from herbal medicines: What have we got from neurotoxic models?
Song, J., Sze, S. C. W., Ng, T., Lee, C., Leung, G., Shaw, P., Tong, Y., & Zhang, Y. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.12.030 · Cited by 102
Phytotherapy in treatment of Parkinson’s disease: a review
Rabiei, Z., Solati, K., & Amini-Khoei, H. (2019) · Pharmaceutical Biology · doi:10.1080/13880209.2019.1618344 · Cited by 97
“Therefore, herbal extracts can be used to treat PD due to various bioactive ingredients (Wang et al. 2008).”
BackgroundTriptolide with Potential Medicinal Value for Diseases of the Central Nervous System
Zheng, Y., Zhang, W., & Wang, X. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12039 · Cited by 89
“The therapeutic effect of triptolide on CNS diseases has attracted worldwide attention, owing to its lipophilic characteristics, small molecular weight (MW 360), and abundant presence in the brain after systemic administration [39,40].”
BackgroundSelf-citationBai, S., Hu, Z., Yang, Y., Yin, Y., Li, W., Wu, L., & Fang, M. (2015) · The Anatomical Record · doi:10.1002/ar.23293 · Cited by 71
“Triptolide is able to cross the blood-brain barrier on account of its size and lipophilic property (Wang et al., 2008).”
BackgroundLin, J., Chen, C., Yang, H.-B., Chen, Y., & Hung, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091846 · Cited by 70
“Benefits of acupuncture treatment include significant increases in the total Unified Parkinson Disease Rating Scale score of PD patients [12].”
Background
Metadata
- Authors
- Wang, X., Liang, X.-B., Li, F.-Q., Zhou, H.-F., Liu, X.-Y., Wang, J.-J., & Wang, X.-M.
- Affiliations
- Capital Medical University (CN)
- Duke Medical Center (US)
- Washington University in St. Louis (US)
- ORCID
- Wang, Xuan
- Venue
- Neurochemical Research
- Published
- 2008-04-11
- Volume
- 33
- Issue
- 10
- Pages
- 1956-1963
- ISSN
- 0364-3190 (ISSN-L)
- 1573-6903
- OpenAlex
- W2030683871
- Cited by
- 58
- References
- 63
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2022: 3 · 2021: 5 · 2019: 4 · 2018: 1 · 2017: 4 · 2016: 4 · 2015: 7 · 2014: 4 · 2013: 2 · 2012: 4
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neurochemical Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science Foundation
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, traditional Chinese medicine, herbal medicine, electroacupuncture, gene therapy, stem cell therapy, neurodegenerative diseases, neuroprotection, treatment options
- MeSH terms
- Animals, Diterpenes, Epoxy Compounds, Glutamate Decarboxylase, Humans, Medicine, Chinese Traditional, Parkinson Disease, Phenanthrenes, Genetic Therapy, Electroacupuncture, Stem Cell Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Therapeutic strategies for Parkinson’s disease: the ancient meets the future–traditional Chinese herbal medicine, electroacupuncture, gene therapy and stem cells. https://app.cochat.ai/papers/10.1007/s11064-008-9691-z
- The paper
- Wang, X., Liang, X.-B., Li, F.-Q., Zhou, H.-F., Liu, X.-Y., Wang, J.-J., & Wang, X.-M. (2008). Therapeutic strategies for Parkinson’s disease: the ancient meets the future–traditional Chinese herbal medicine, electroacupuncture, gene therapy and stem cells. Neurochemical Research. https://doi.org/10.1007/s11064-008-9691-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.